#RegulatoryStrategy
LightNews LightNews
cbdpope.bsky.social
Export permits signed,
While others wait for license
Preparation meets opportunity.

#CBDPope #Haiku #ExportPermits #PreparationMeetsOpportunity #RegulatoryStrategy
#EUGMP #CannabisExport #InternationalTrade #CannabisIndustry #BusinessStrategy
August 14, 2025 at 1:29 PM
creatioub.bsky.social
🚀 Registration is open: Technical and Legal Requirements for ATMP Development Training Session

📅 2 June 2026 | 9:30 am
📍 Parc Científic de Barcelona

👉 Register bit.ly/ATMPsession

#ATMP #RegulatoryStrategy #ClinicalTranslation
@ub.edu @ubneuro.bsky.social @idibaps.bsky.social @www.pcb.ub.edu
May 8, 2026 at 11:19 AM
lumanity.bsky.social
Interactions with the U.S. #FDA represent some of the most pivotal moments in the product development lifecycle. Access key strategies to ensure your organization makes the most of every #FDA interaction: buff.ly/9zkotWO

#DrugDevelopment #RegulatoryStrategy #ClinicalDevelopment #RegulatoryAffairs
December 1, 2025 at 8:02 PM
antitrustintel.bsky.social
www.linkedin.com/posts/aitor-...

#competitionlaw #regulatorystrategy #CMA #marketstudy #brandpower #antitrust #investors #FMCG #retailrisk
Danone, Nestlé Risk Margin Erosion After CMA Baby Formula Report | Aitor Ortiz
🚨 𝗡𝗼 𝗳𝗶𝗻𝗲𝘀. 𝗡𝗼 𝗱𝗮𝘄𝗻 𝗿𝗮𝗶𝗱𝘀. 𝗡𝗼 𝗳𝗼𝗿𝗺𝗮𝗹 𝗶𝗻𝘃𝗲𝘀𝘁𝗶𝗴𝗮𝘁𝗶𝗼𝗻. 𝗬𝗲𝘁, 𝗲𝗳𝗳𝗲𝗰𝘁𝗶𝘃𝗲. Danone and Nestlé, who dominate the…
www.linkedin.com
March 25, 2025 at 3:16 PM
strategicforesight.streetwi.se.ap.brid.gy
In about a month, you'll have a repeatable habit for spotting regulatory changes early. Instead of reacting to surprises, you'll be planning for them. That's a real edge in advisory work. #strategicforesight #regulatorystrategy #foresightinaction #strategy #riskintelligence #strategicanalysis […]
Original post on streetwi.se
streetwi.se
May 25, 2026 at 6:08 PM
genelife.bsky.social
India's 2026 NDCT amendments: what actually changed vs what the headlines suggested.
Changed: pre-clinical manufacturing approval → prior intimation. BA/BE initiation. Review timeline 90 → 45 days.

#ClinicalTrials #India #CDSCO #NDCT2026 #RegulatoryStrategy #DrugDevelopment #Pharma #CRO
India's 2026 Clinical Trial Regulatory Reforms: What Small Molecule Sponsors Need to Know — and What Has Not Changed
Genelife, Clinical Research, GCP, Medical Device, Patient Recruitment, Asthma, Oncology, Ophthalmology, Clinical Trials, Cancer, tuberculosis
genelifecr.blogspot.com
September 3, 2026 at 5:43 AM
xsbrt.bsky.social
Domestic plants = approval speed? Yes. Tip: prioritize US manufacturing and vetted domestic generic inputs to unlock priority review pathways and shave months off FDA timelines. Full breakdown → https://future.xsbrt.com/DomesticDrugResilienceFuture Saves/replies welcome. #regulatorystrategy
August 10, 2026 at 11:03 PM
genelife.bsky.social
The clinical programs that succeed are the ones designed by people who understand this — and build their strategy around it from day one.

#MedicalDevices #ClinicalResearch #DeviceTrials #EUMDR #FDA #CRO #RegulatoryStrategy

genelifecr.blogspot.com/2026/07/the-...
The Constraints in Medical Device Clinical Trials: Why Device Research Is Harder Than It Looks
Genelife Expertise in Medical Device Clinical Trials
genelifecr.blogspot.com
July 6, 2026 at 7:47 AM
obipharma.bsky.social
Our CEO, Dr. Heidi Wang, was invited to speak at Biologics World Taiwan 2026.
She shared insights on global regulatory strategy and drug development from IND to NDA.
🔗 Read more: lnkd.in/gEJci5TH
#OBIPharma #RegulatoryStrategy #DrugDevelopment #ADC #BWT2026 #BiologicsWorldTaiwan #IMAPAC
lnkd.in
March 26, 2026 at 7:42 AM
orson-johnson.bsky.social
The Beginner's Secret to General Mills Politics

https://statebudgets.online/the-beginners-secret-to-general-mills-politics/?utm_source=bluesky&utm_medium=social
#generalmillsfoodlabeling #foodindustrylobbying #regulatorystrategy
June 7, 2026 at 9:21 PM
confidentstrategy.bsky.social
Introducing breakthrough food‑tech innovation while staying true to what consumers see as natural. 🌱✨

confidentstrategygroup.com/work/natural...

#FoodTech #Sustainability #Innovation #NaturalIngredients #FutureOfFood #RegulatoryStrategy #BrandPositionin #ConfidentStrategyGroup #WeAreConfident
Natural and Sustainability Position for Food Ingredients Company - CSG
Developing a natural and sustainability positioning for a food ingredients company, aligning new technology with regulatory, industry, and consumer expectations.
confidentstrategygroup.com
February 25, 2026 at 2:03 PM
genelife.bsky.social
India's biosimilar regulatory framework has changed more in the last decade than most development teams realize.

#Biosimilars #ClinicalResearch #RegulatoryStrategy #CDSCO #Biologics #Pharma #CRO
June 12, 2026 at 10:31 AM
genelife.bsky.social
Drug–device combination products are more complex. The regulations are more demanding. The opportunity is bigger than ever.
#CombinationProducts #MedicalDevices #Pharma #RegulatoryStrategy #DigitalHealth #ClinicalResearch
genelifecr.blogspot.com/2026/05/drug...
Drug–Device Combination Products: Revisiting the Challenges, Thirteen Years On
Drug–Device Combination Products: Challenges and Evolution in Clinical Research
genelifecr.blogspot.com
May 29, 2026 at 4:48 PM
catalyst-bc.bsky.social
MN Cannabis has graduated. 🎓 No more experiments - just a $50M+ science-first ecosystem. 🧪

Don't let the "Execution Gap" stall your cannabis business scale-up. Stay ahead with our 2026 Strategic Analysis: zurl.co/XuXqF

#MNCannabis #RegulatoryStrategy #MNBusiness
Navigating the Minnesota Social Equity and Cannabis Licensing Landscape: 2026 Comprehensive Strategic Analysis
Master the 2026 Minnesota OCM social equity rules. Learn about 65% ownership rule, "Pharma-Grade" SOP standards, & latest SEA licensing stats.
zurl.co
May 7, 2026 at 6:22 PM
lumanity.bsky.social
Are you prepared for how the FDA plans to drastically reduce animal testing and how it may impact your pipeline? Check out Lumanity's perspective in a recent pharmaphorum article: buff.ly/axmMlIv

#DrugDevelopment #RegulatoryStrategy #NAMs #Oncology #FDA #PharmaInnovation
Photo of Jennifer Burke, Lumanity Clinical & Regulatory expert authors an article on FDA animal testing.
January 14, 2026 at 4:00 PM
lumanity.bsky.social
#ICYMI: Check out our latest article, “De-Risking IND Submissions to Accelerate FDA Clearance" to explore the five most common reasons INDs are put on hold, and how the right preparation helps mitigate the risk: buff.ly/VzTW1za

#IND #FDA #Regulatory #RegulatoryStrategy #ClinReg
Text: View. De-Risking IND Submissions to Accelerate FDA Clearance. Lumanity logo.
September 19, 2025 at 7:01 PM
dantweb.bsky.social
Target SOL, XRP, and ADA as next-wave ETF candidates capitalizing on regulatory shifts and institutional demand. #AltcoinETFs #CRyptoIdeas #InvestmentIdeas #RedRobotIdeas #RegulatoryStrategy
redrobot.online/2025/05/cryp...
July 13, 2025 at 10:15 PM
dantweb.bsky.social
Target SOL, XRP, and ADA as next-wave ETF candidates capitalizing on regulatory shifts and institutional demand. #AltcoinETFs #CRyptoIdeas #InvestmentIdeas #RedRobotIdeas #RegulatoryStrategy
redrobot.online/2025/05/cryp...
July 13, 2025 at 10:15 PM
market-ocean-en.bsky.social
outcomes in capital-intensive technology sectors, making policy analysis essential alongside traditional financial metrics. #USChinaTech #IndustrialPolicy #RegulatoryStrategy
November 21, 2025 at 4:20 AM
amitrakhit.bsky.social
I'm excited to join the Regulatory Panel at #LongwoodHealthcareLeaders MIT CEO, tomorrow at 3 PM! We'll dive into #RegulatoryStrategy with an amazing group of leaders. Agenda: www.longwoodhealthcareleaders.com/mitceo #BiotechLeadership
I'm excited to join the Regulatory Panel at #LongwoodHealthcareLeaders MIT CEO, tomorrow at 3 PM! We'll dive into #RegulatoryStrategy with an amazing group of leaders. Agenda: www.longwoodhealthcareleaders.com/mitceo #BiotechLeadership
June 16, 2025 at 3:16 PM
bluefrogscientific.bsky.social
UK–EU SPS Negotiations Could Realign GB with EU Biocides & Pesticides Regulations.

Learn more... www.bluefrogscientific.com/c...

#SPS #PlantProtectionProducts #PPP #Pesticides, #Biocides #BiocidalProducts #BPR #RegulatoryStrategy #BiocideRegulation #PesticideRegulation
March 11, 2026 at 11:52 AM
bluefrogscientific.bsky.social
Big Challenges Remain for Nanomaterials Under REACH.

REACH compliance for nanomaterials isn't straightforward, but is achievable...

www.bluefrogscientific.com/c...

#Nanomaterials #Nanoforms #REACHCompliance #ChemicalRegulation #NanoRegulation #RegulatoryScience #RegulatoryStrategy
June 12, 2025 at 9:15 AM
comparchitects.bsky.social
Join Compliance Architects at MDMES in Austin from February 16-18. Our team will be at Booth 12, ready to discuss the latest in quality compliance. We look forward to meeting you! #MDMES25 #QualityCompliance #MedicalDevices #RegulatoryStrategy #ComplianceArchitects
February 5, 2025 at 6:36 PM
synterex.bsky.social
In rare diseases, the “n of 1” matters, and efficacy narratives help tell that story with clarity and impact. For more on #EfficacyNarratives in #RareDiseases, read our latest LinkedIn post: www.linkedin.com/feed/update/...

#ClinicalDevelopment #RegulatoryStrategy #OrphanDrugs
Services | Synterex | Synterex
In rare disease development, regulatory decision-making often hinges on limited, non-traditional data. Common challenges that arise in the rare disease space include small sample sizes, single-arm or ...
www.linkedin.com
October 9, 2025 at 5:15 PM